| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |